Bavarian Nordic A/S (OTCMKTS:BVNRY) Shares Pass Below 200-Day Moving Average – Here’s What Happened

Shares of Bavarian Nordic A/S (OTCMKTS:BVNRY) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.84 and traded as low as $9.36. Bavarian Nordic A/S shares last traded at $9.39, with a volume of 7,157 shares trading hands.

Bavarian Nordic A/S Stock Performance

The stock has a market capitalization of $2.22 billion, a PE ratio of 21.34 and a beta of 1.71. The stock has a 50-day moving average price of $10.95 and a two-hundred day moving average price of $9.84.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last posted its quarterly earnings data on Thursday, August 22nd. The company reported $0.16 earnings per share for the quarter. Bavarian Nordic A/S had a return on equity of 12.50% and a net margin of 11.50%. The firm had revenue of $205.99 million for the quarter. As a group, equities analysts predict that Bavarian Nordic A/S will post 0.57 earnings per share for the current year.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.